Risk Factors for Poor Adherence to Eyedrops in Electronically Monitored Patients with Glaucoma

• Published in: Ophthalmology (Rochester, Minn.) Vol. 116; no. 6; pp. 1097 - 1105
• Main Authors: Friedman, David S., Okeke, Constance O., Jampel, Henry D., Ying, Gui-shuang, Plyler, Ryan J., Jiang, Yuzhen, Quigley, Harry A.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.06.2009; Elsevier
• Subjects: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents - administration & dosage; Biological and medical sciences; Cloprostenol - administration & dosage; Cloprostenol - analogs & derivatives; Drug Monitoring - instrumentation; Ethnic Groups; Female; Follow-Up Studies; Glaucoma - drug therapy; Glaucoma - ethnology; Glaucoma and intraocular pressure; Health Knowledge, Attitudes, Practice; Humans; Intraocular Pressure - drug effects; Male; Medical sciences; Medication Adherence - statistics & numerical data; Middle Aged; Miscellaneous; Ocular Hypertension - drug therapy; Ocular Hypertension - ethnology; Ophthalmic Solutions - administration & dosage; Ophthalmology; Prospective Studies; Risk Factors; Surveys and Questionnaires; Travoprost; Glaucoma; Human; Protozoa; Eye disease; Glaucoma (eye); Risk factor; Ciliata; Ophthalmology; Adhesion

To identify risk factors for poor adherence to topical once daily therapy for glaucoma. Prospective, observational cohort study. A total of 196 patients with glaucoma who were being treated with a prostaglandin analog in 1 or more eyes at the Scheie or Wilmer Eye Institutes between August 2006 and J...